Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Institut Cancerologie de l'Ouest
InSightec
H. Lee Moffitt Cancer Center and Research Institute
UNC Lineberger Comprehensive Cancer Center
Virginia Commonwealth University
Maastricht Radiation Oncology
Hellenic Cooperative Oncology Group
Washington University School of Medicine
MedSIR
Thomas Jefferson University
Inova Health Care Services
Cedars-Sinai Medical Center
Taproot Health
University of Chicago
University of Southern California
Stanford University
National Cancer Institute (NCI)
Seagen Inc.
Mayo Clinic
Quadriga Biosciences, Inc.
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
US Oncology Research
Dana-Farber Cancer Institute
Eli Lilly and Company
DEKK-TEC, Inc.
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Celgene
National Institutes of Health Clinical Center (CC)
Angiochem Inc
Chinese PLA General Hospital
Novartis
Stanford University
IGF Oncology, LLC
Swiss Cancer Institute
Novartis
AC Camargo Cancer Center
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center
Institut Paoli-Calmettes
University of California, San Francisco
University of Washington
Roswell Park Cancer Institute
Angiochem Inc
Sanofi
Memorial Sloan Kettering Cancer Center
Mayo Clinic